Asa Elmore | Sutro Biopharma, Inc.

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit

Events, News, Presentations, Press Releases

Sutro Biopharma to Participate in the JMP Securities Hematology and Oncology Summit SOUTH SAN FRANCISCO, Calif., December 4, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...

Piper Sandler 35th Annual Healthcare Conference – Presentation

Events, News, Presentations

Piper Sandler 35th Annual Healthcare Conference – Presentation...

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates

News, Press Releases

Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates — Vaxcyte Obtains Exclusive Rights to Independently Develop and...

Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer

News, Press Releases

Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer SOUTH SAN FRANCISCO, Calif., November 21, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...

Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones

News, Press Releases

Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones – Updated luvelta data from Compassionate Use Access demonstrating anti-leukemic activity in pediatric patients with relapsed/refractory...

« Older Entries